1Read R W, Holland G N, Rao N A, et al.Revised diagnostic criteria for V K H disease: report of an international committee on nomenlalure[J] .AmJOphthalmol, 2001, 131 (5): 647-652.
2Bouchenaki N, Herbort C P.The contribution of indocyanine green angiography to the appraisal and management of Vogt - Koyanagi Haradadisease [J] .Ophthalmology, 2001, 108: 54-64.
3Zhao M, Jiang Y, Abrahams I W.Association of HLA antigens with Vogt- Koyanagi - Harada syndrom in a Han Chinese population [J] .Arch Ophthalmol, 1991, 109: 368- 370.
4Rubsamen P E, Gass D M.Vogt - Koyanagi - Harada Syndrome: Clinicalcourse, Therapy, and Long- term Visual outcome [J] .Arch Ophthalmol, 1991, 109: 682-687.
5Snyder D A, Tessler H H.Vogt - Koyanagi - Harada Syndrome [J] .Am J Ophthalmol, 1980, 90: 69-75.
5Hu TS,Liu Q,Zhang MF.Association with HLA-DRB1 * 0405,-DQA1*0301, -DQB1*0401 in patients with Vogt-Koyanagi-Harada syndrome[].Investigative Ophthalmology.1999
6Sugiura S.Vogt-Koyanagi-Harada disease[].Japanese Journal of Ophthalmology.1978
7Synder DA,Tessler HA.Vogt-Koyanagi-Harada Syndrome[].American Journal of Ophthalmology.1980
8Inomata H,Sakamoto T.Immunohistochemical studies of VogatKoyanagi-Harada disease with sunset sky fundus[].Current Eye Research.1990
9Shindo Y,Ohno S,Usui M,et al.Immunogenetic study of sympathetic ophthalmia[].Tissue Antigens.1997
10Woods AC.Sympathetic ophthalmia[].American Journal of Ophthalmology.1936
1Bouehenake N, Herbort C P. The Contribution of Indoeyanine Green Angiography to the Appraisal and Management of Vogt-Koyanagi-Harada Disease [J]. Ophthalmology, 2001, 108 ( 1 ) : 54-64.
2Paredes I, Ahmed M, Foster C S. Immunomodulatory Therapy for Vogt-Koyanagi-Harada Patient as First-line Therapy[J]. Ocul Immunol Inflamm, 2006,14 (2): 87-90.
3Read R W, Holland G N,Rao N A,et al. Revisde Diagnostic Criteria for Vogt-Koyanagi-Harada Desease: Report of an International Committee on Nomenclature [J]. Am J Ophthalmol, 2001,131(5) :647-652.
